Device Trial Radar · NCT02021617
Infusion Flow Rates and Blood Sampling
Last checked: Nov 20, 2026Latest source record: Oct 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
20
Actual
Start
Nov 5, 2013
Primary completion
Nov 15, 2013
Study completion Nov 15, 2013
Sponsor
- Lead sponsor
- Vidacare CorporationNot on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 27, 2013
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Health services research
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
* To evaluate infusion flow rates attainable when using the proximal humerus and proximal tibia IO vascular access sites. * To evaluate the intraosseous infusion physiology when using the proximal humerus and proximal tibia IO infusion sites. * To further evaluate the relationship between IO and venous blood when used for laboratory testing. * To determine the time from IO needle insertion to IO access established.
Conditions
- Intraosseous Access
- Infusion Rates
- Intraosseous Blood
- Venous Blood
Interventions
Intraosseous accessDevice
The EZ-IO Intraosseous Vascular Access System (Vidacare Corporation, Shavano Park, TX, USA) has been cleared by the U.S. Food and Drug Administration, Health Canada, and the European Union for the administration of drugs and fluids anytime vascular access is difficult to obtain in emergent, urgent, or medically necessary cases. It consists of a driver-a small battery-powered drill-and a needle set designed for insertion into the IO space of the proximal tibia, distal tibia, or proximal humerus. Needles are 15 gauge and available in three lengths: 15 mm, 25 mm, and 45 mm. In this study the 45 mm EZ-IO needle set will be used for all humeral placements and the 25 mm needle set will be used for all tibial placements.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Infusion Flow RatesTime frame: 1 Day
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Bulverde Spring Branch EMS
Spring Branch, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.